检索
AI 对话
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

Trial in progress: linvoseltamab, a BCMAxCD3 bispecific antibody, in a Phase 1b multi-cohort study of combination regimens for patients with relapsed/refractory multiple myeloma

Paula Rodriguez-Otero,Nisha Joseph,Shaji Kumar,Xavier Leleu,Salomon Manier,Meletios Dimopoulos,Maria-Victoria Mateos,Albert Oriol,Naresh Bumma, Weiying Gong,Pourab Roy,Karen Rodriguez Lorenc,Glenn Kroog, Shawn Sarkaria

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA（2023）

引用 0|浏览7
暂无评分
关键词
multiple myeloma,bcmaxcd3 bispecific antibody,linvoseltamab,multi-cohort
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要